Insider · CIK 0002147293
Barry Hassett
Files at BSEM (BioStem Technologies, Inc.). First filing -, latest -.
Barry Hassett files SEC Form 4 as officer at BSEM (BioStem Technologies, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Barry Hassett has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | BSEM BioStem Technologies, Inc. | MOption exercise Common Stock | +500 | $0.00 | $0 | 5,003 | 32 d ago |
| Sep 9, 2026 | BSEM BioStem Technologies, Inc. | MOption exercise Restricted Stock Unitsderivative | -500 | $0.00 | $0 | 4,497 | 32 d ago |
Questions about Barry Hassett
Answered from the filings on this page, as of the latest one.
Is Barry Hassett buying or selling?
Barry Hassett has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Barry Hassett's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Barry Hassett has 0.
Where does Barry Hassett file Form 4?
Barry Hassett has filed Form 4 at BSEM (BioStem Technologies, Inc.) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.